INDIA LIVE DESKNIFTY 50:23,140.50(+0.34%)SENSEX:73,895.74(+0.43%)
RDU Global
šŸ‡®šŸ‡³
šŸ‡®šŸ‡³ India Edition • Markets, IPOs & WealthRDU GLOBAL CORRESPONDENT
VERIFIED WIRE INTELLIGENCE

"Five Signals That Could Bring Foreign Investors Back to Indian Stocks"

Foreign portfolio investors sold more than Rs 25,000 crore of Indian equities in September as higher US bond yields, firm crude prices and a weaker rupee eroded the market’s relative appeal. A reversal in those macro pressures, combined with strong second-quarter earnings and more attractive valuations, could help rebuild foreign buying interest in the weeks ahead.

Five Signals That Could Bring Foreign Investors Back to Indian Stocks

R

RDU Global Wire

Markets & Wealth Desk

New Delhi, India 04 Oct 2026, 11:28 PM IST•5 min read

Foreign portfolio investors sold more than Rs 25,000 crore of Indian equities in September as higher US bond yields, firm crude prices and a weaker rupee eroded the market’s relative appeal. A reversal in those macro pressures, combined with strong second-quarter earnings and more attractive valuations, could help rebuild foreign buying interest in the weeks ahead.

Foreign investors have pulled back sharply from Indian equities in recent weeks, underscoring how quickly global macro conditions can overwhelm domestic optimism. In September alone, foreign portfolio investors sold more than Rs 25,000 crore worth of Indian stocks, a reminder that India's long-term growth story does not automatically shield it from shifts in global capital flows. The latest outflows were driven by a difficult mix: rising US Treasury yields, elevated crude oil prices and a softer rupee, all of which made Indian assets less compelling on a relative basis.

Yield Pressure Eases

The first and most immediate condition for a return of foreign buying is a cooling in US bond yields. When American yields rise, the risk-free return available in the world's largest financial market becomes more attractive, prompting global investors to reassess exposure to emerging markets. India, despite its strong structural growth narrative, is not immune to that rotation. A stabilisation or decline in US yields would reduce the opportunity cost of holding Indian equities and could trigger renewed interest from global funds that have been sitting on the sidelines.

That dynamic matters because foreign investors often trade Indian stocks not only on domestic fundamentals but also on global relative value. If the yield premium in the United States narrows, India's equity market can regain some of its appeal, particularly in sectors with durable earnings growth and strong balance sheets. The market has already shown how sensitive flows are to this variable, with September's selling reflecting a broader de-risking trend across emerging markets.

Oil And Currency Stability

The second and third factors are closely linked: crude oil prices and the rupee. India remains a large importer of energy, so higher oil prices tend to widen the current account deficit, pressure inflation and complicate the policy outlook. For foreign investors, expensive crude is not just a macro headline; it is a direct threat to corporate margins, consumer demand and currency stability. When oil rises, India's external balance becomes more vulnerable, and that tends to weigh on portfolio sentiment.

A stable rupee is equally important. Currency weakness can erase equity gains for overseas investors even when local stock prices rise. In recent weeks, the softer rupee has amplified the discomfort created by higher US yields and firmer oil, making Indian assets less attractive on a hedged or unhedged basis. A period of currency stability, supported by manageable oil prices and a more balanced external account, would go a long way toward restoring confidence.

Earnings And Valuations

The fourth and fifth factors are domestic and may prove decisive if the global backdrop improves: strong second-quarter earnings and attractive valuations. Foreign investors are unlikely to return in force unless company results confirm that India's growth momentum remains intact. Robust earnings from banks, consumer firms, industrials and select technology names would reinforce the view that India can deliver both growth and profitability even in a mixed global environment.

Valuations also matter more when global uncertainty is high. After a period of strong domestic inflows and sustained market gains, parts of the Indian market are no longer cheap by historical standards. But relative valuation is what counts for foreign capital. If earnings continue to compound and prices consolidate, India may once again look compelling compared with other emerging markets and developed-market alternatives. That is especially true for long-only funds seeking quality growth at a reasonable price.

The broader message is that foreign buying is unlikely to return on sentiment alone. It will require a convergence of supportive macro signals: lower US yields, softer oil, a steadier rupee, credible earnings delivery and valuations that justify fresh allocations. India's structural story remains intact, but in the near term, global liquidity and macro stability will determine whether foreign investors come back in a meaningful way. Until then, the market may continue to rely more heavily on domestic institutional support to absorb overseas selling and keep the broader rally intact.

Editorial & Verification Notice

Reported by RDU Global Correspondent. Formatted and verified using real-time institutional and journalistic wire feeds. Independent reporting adhering to the RDU Global Editorial Code of Conduct.

Entity Intelligence & Connected Dossiers

Cross-referenced topic files, verified public records, and institutional tracking

Knowledge Graph
šŸ¢Companies & Institutions:
šŸ“Locations & Geopolitics:

Related Coverage

Markets, IPOs & Wealth

Healthcare’s Next Market Cycle Is Being Built by Sensors, Skin and Software

A new wave of medical technology is moving from research labs into commercial markets, with wearables, 3D-printed tissue, reconstructed organs and AI-enabled clinical trials reshaping how care is delivered and financed. For investors, the shift signals a broader re-rating of healthcare innovation, where data-rich devices and personalized medicine could define the next IPO and growth cycle.

04 Oct 2026, 11:07 PM IST
Markets, IPOs & Wealth

Sebi Building Second Surveillance System to Flag ā€˜Bad Elements’ in Listed Companies, Varshney Says

The Securities and Exchange Board of India is developing a second surveillance system to identify ā€œbad elementsā€ among listed companies, according to a senior official, as the regulator sharpens its market oversight tools. The move also includes a closer screen for small initial public offerings that may not be suitable for the capital market, signalling a more selective approach to market access and post-listing monitoring.

04 Oct 2026, 10:24 PM IST
Markets, IPOs & Wealth

IPO-Bound Kuku Technologies Turns Profitable in FY26 as Revenue Jumps Sixfold to ₹1,484 Crore

Kuku Technologies Limited, the parent of audio OTT platform Kuku FM and microdrama app Kuku TV, has swung to profitability in FY26 while posting a dramatic surge in revenue to ₹1,484 crore, according to the latest business update. The performance marks a major inflection point for the startup ahead of a potential public-market debut, underscoring stronger monetisation across India’s fast-evolving creator and short-form entertainment economy.

04 Oct 2026, 08:54 PM IST